NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
* Return to Hepatitis Alert Section

Reports outline hepatitis B virus therapy study findings from Hospital General Universitario, Department of Biochemistry



December 15th, 2008

   2008 DEC 15 -- Scientists discuss in 'Analysis of hepatitis B genotype changes in chronic hepatitis B infection: Influence of antiviral therapy' new findings in hepatitis B virus. "The frequency of mixed hepatitis B virus (HBV) genotypes in chronic HBV (CHB) and genotype changes during natural disease evolution and as a result of antiviral therapy were investigated. Serum samples from 103 CHB patients were included in a cross-sectional study," researchers in Barcelona, Spain report.

   "Longitudinal study of HBV genotypes was performed in 22 patients, 17 of them under antiviral therapy (lamivudine and/or adefovir). HBV genotyping was done by the INNO-LiPA HBV assay. Genotypes observed in the cross-sectional study: A 32% of cases, D 42%, C 2%, F 2%, and mixed genotypes 22% (mainly A/D, followed by A/G). Genotype G was found in 7% of patients, always combined with other genotypes. In the longitudinal study, genotype changes were observed only in treated patients (9 cases). Genotype A strains were positively selected in 6 of them, mainly as mixed A/D. In 6 patients, selection coincided with a decrease in HBV-DNA levels. A high frequency of mixed HBV genotypes was observed in our setting. Selection of genotype A strains during treatment is likely an indication that sensitivity to therapy differs between genotypes A and D," wrote R. Jardi and colleagues, Hospital General Universitario, Department of Biochemistry.

   The researchers concluded: "The absence of changes in untreated patients suggests that HBV genotype is stable without external factors."

   Jardi and colleagues published their study in the Journal of Hepatology (Analysis of hepatitis B genotype changes in chronic hepatitis B infection: Influence of antiviral therapy. Journal of Hepatology, 2008;49(5):695-701).

   For additional information, contact R. Jardi, Hospital General Universitario Vall d'Hebron, Dept. of Biochemistry, Paseo Valle Hebron s, n, Servicio de Bioquimica, Barcelona 08035, Spain.

   Publisher contact information for the Journal of Hepatology is: Elsevier Science BV, PO Box 211, 1000 AE Amsterdam, Netherlands.

   Keywords: Spain, Barcelona, Hepatitis B Virus Therapy, Antiviral, Biochemistry, Chronic Hepatitis B, Drugs, Gastroenterology, Genotyping, HBV, Hepatitis B Virus, Hepatology, Infectious Disease, Lamivudine, Pharmaceuticals, Treatment, Viral Inhibition, Viral Therapy, Virology.

   This article was prepared by Biotech Business Week editors from staff and other reports. Copyright 2008, Biotech Business Week via NewsRx.com.

Return to Hepatitis Alert Section

NewsRx Passes
Advertisement
------------------------
Security by Verisign PR Login